We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Therapeutic Antibodies – News and Features

News

MorphoSys and OncoMed Sign Agreement for use of HuCAL GOLD® in Cancer Research

MorphoSys grants OncoMed access to its antibody library HuCAL GOLD® for use by OncoMed in its drug discovery programs.
News

Lilly Breast Cancer Studies Explore Potential Role of Pharmacogenomics in Customizing Chemotherapy

Lilly has unveiled two breast cancer studies involving pharmacogenomics and its chemotherapies GEMZAR® (gemcitabine HCl) and ALIMTA® (pemetrexed).
News

EvoGenix Announces Antibody Collaboration with CSL

EvoGenix will apply its proprietary technologies to antibody products selected by CSL from its pipeline.
News

KaloBios Collaborates to Engineer Human Antibody Therapeutic Drugs

Genomics Institute of the Novartis Research Foundation's non-human antibody drug candidate was humaneered™ by KaloBios.
News

XOMA and Schering-Plough Establish Collaboration for Therapeutic Antibody Discovery and Development

The collaboration is intended to capitalize on XOMA's antibody discovery, development and production technologies and expertise.
News

Dyax and ICOS Enter Into License Agreement for Discovery of Therapeutic Antibodies

The agreement provides ICOS with a license to Dyax's antibody phage display technology and patent rights.
News

ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech

Companies also amend 2000 agreement for TAP compounds targeting HER2, potentially providing increased royalties and milestones to ImmunoGen.
News

Alexion's Antibody Therapy Shown Effective in Model for Severe Allergic Asthma

Findings show treatment with anti-C5 complement antibody reduced airway inflammation when used with standard nebulizer.
News

OGeS and Medarex Sign Therapeutic Antibody Collaboration Agreement in Cancer

The collaboration combines OGeS' ability to discover targets for oncology with Medarex's expertise in the development of fully human antibody therapeutics.
News

Immunomedics and IBC Pharmaceuticals Report on a Novel Protein Engineering Platform Technology

The technology may enable the creation of virtually any multifunctional protein for diverse applications.
Advertisement